<DOC>
	<DOCNO>NCT00963131</DOCNO>
	<brief_summary>Central serous chorioretinopathy ( CSC ) serous neurosensory detachment usually involve macular area . It common patient 30-50 year old effect male often female ratio 5-10 . The common risk factor psychologic stress , type A personality , systemic steroid use , hypertension pregnancy . The treatment usually observation especially first three-months . The laser photodynamic therapy consider condition improve time . Nevertheless , pathogenesis CSC still well understood study indocyanine green angiography show choroidal vascular hyperpermeability abnormal leakage . The cause abnormality suppose nitric oxide , prostaglandin even free oxidative radical . From hypothesis , oxidative process might involve pathogenesis disease especially early stage . This study determine effect antioxidant drug acute stage CSC determine whether improve outcome disease .</brief_summary>
	<brief_title>High-dose Antioxidants Central Serous Chorioretinopathy</brief_title>
	<detailed_description />
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>1. patient acute central serous chorioretinopathy within 6 week onset 2. age 3050 year 3. new recurrent attack ( symptomfree period longer 6 month ) 4. fluorescein angiography ( FA ) confirm diagnosis inkblot smokestack leakage optical coherence tomography ( OCT ) show definite subretinal fluid 5. patient ' ability proper follow . 1. chronic central serous chorioretinopathy ( longer 6 week ) 2. complicated central serous chorioretinopathy secondary choroidal neovascularization ( CNV ) detect FA 3. pregnancy , steroid user patient contraindicate high dose antioxidant therapy heavy smoker , lung cancer , thyrotoxicosis , renal stone anemia ( hematocrit le 30 % ) .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Central serous chorioretinopathy , antioxidant</keyword>
</DOC>